The shed P2X7 receptor is an index of adverse clinical outcome in COVID-19 patients - Concepedia

Concepedia

Publication | Open Access

The shed P2X7 receptor is an index of adverse clinical outcome in COVID-19 patients

DOI Full Paper Access

11

Citations

41

References

2023

Year

Valentina Vultaggio-Poma, Juana María Sanz, Andrea Amico, Alessandra Violi, Sara Ghisellini, Stefano Pizzicotti, Angelina Passaro, Alberto Papi, Marco Libanore, Francesco Di Virgilio,

Frontiers in Immunology

Abstract

Blood sP2X7R was elevated in the early phases of COVID-19 and predicted an adverse clinical outcome. It is suggested that sP2X7R might be a useful marker of disease progression.

References

	Year	Citations

Page 1